These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8569998)
1. Gompertzian analysis of amyotrophic lateral sclerosis mortality in Italy, 1957-1987; application to birth cohorts. Chiò A; Magnani C; Schiffer D Neuroepidemiology; 1995; 14(6):269-77. PubMed ID: 8569998 [TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Chiò A; Magnani C; Schiffer D Neurology; 1993 May; 43(5):927-30. PubMed ID: 8492947 [TBL] [Abstract][Full Text] [Related]
3. Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study. Nakken O; Lindstrøm JC; Tysnes OB; Holmøy T J Neurol; 2016 Dec; 263(12):2378-2385. PubMed ID: 27586392 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset. Riggs JE Mech Ageing Dev; 1990 Sep; 55(3):207-20. PubMed ID: 2232913 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies. Ragonese P; Filippini G; Salemi G; Beghi E; Citterio A; D'Alessandro R; Marini C; Monsurrò MR; Aiello I; Morgante L; Tempestini A; Fratti C; Ragno M; Pugliatti M; Epifanio A; Testa D; Savettieri G Neuroepidemiology; 2004; 23(1-2):73-7. PubMed ID: 14739571 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal Gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimates of susceptibility in the general population. Neilson S; Robinson I; Hunter M Mech Ageing Dev; 1992 Jun; 64(1-2):201-16. PubMed ID: 1630157 [TBL] [Abstract][Full Text] [Related]
7. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G; Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545 [TBL] [Abstract][Full Text] [Related]
8. Static and dynamic models of interdisease competition: past and projected mortality from amyotrophic lateral sclerosis and multiple sclerosis. Neilson S; Robinson I; Hunter M Mech Ageing Dev; 1993 Jan; 66(3):223-41. PubMed ID: 8469015 [TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. Chiò A; Cucatto A; Calvo A; Terreni AA; Magnani C; Schiffer D J Neurol; 1999 Mar; 246(3):175-80. PubMed ID: 10323314 [TBL] [Abstract][Full Text] [Related]
10. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. Neilson S; Robinson I; Alperovitch A J Neurol; 1994 Jun; 241(7):448-55. PubMed ID: 7931447 [TBL] [Abstract][Full Text] [Related]
11. Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiologic study. Giagheddu M; Mascia V; Cannas A; Pirastru MI; Sanna F; Rachele MG; Brundu A; Murgia B Acta Neurol Scand; 1993 Jun; 87(6):446-54. PubMed ID: 8356872 [TBL] [Abstract][Full Text] [Related]
12. Cross-sectional Gompertzian analysis: the development of a Gompertz mortality ratio (GMR) and its applicability. Neilson S; Robinson I Mech Ageing Dev; 1993 May; 68(1-3):137-49. PubMed ID: 8350654 [TBL] [Abstract][Full Text] [Related]
13. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. Chiò A; Calvo A; Bovio G; Canosa A; Bertuzzo D; Galmozzi F; Cugnasco P; Clerico M; De Mercanti S; Bersano E; Cammarosano S; Ilardi A; Manera U; Moglia C; Sideri R; Marinou K; Bottacchi E; Pisano F; Cantello R; Mazzini L; Mora G; JAMA Neurol; 2014 Sep; 71(9):1134-42. PubMed ID: 25048026 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. Chiò A; Magnani C; Oddenino E; Tolardo G; Schiffer D J Epidemiol Community Health; 1992 Oct; 46(5):517-8. PubMed ID: 1479322 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. Neilson S; Robinson I; Nymoen EH J Neurol Sci; 1994 Apr; 122(2):148-54. PubMed ID: 8021698 [TBL] [Abstract][Full Text] [Related]
16. Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Uccelli R; Binazzi A; Altavista P; Belli S; Comba P; Mastrantonio M; Vanacore N Eur J Epidemiol; 2007; 22(11):781-90. PubMed ID: 17874192 [TBL] [Abstract][Full Text] [Related]
17. Rising mortality due to Parkinson's disease and amyotrophic lateral sclerosis: a manifestation of the competitive nature of human mortality. Riggs JE; Schochet SS J Clin Epidemiol; 1992 Sep; 45(9):1007-12. PubMed ID: 1432014 [TBL] [Abstract][Full Text] [Related]
18. Amyotrophic lateral sclerosis mortality rates in Chile: A population based study (1994-2010). Valenzuela D; Zitko P; Lillo P Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):372-7. PubMed ID: 25859694 [TBL] [Abstract][Full Text] [Related]
19. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Pupillo E; Messina P; Logroscino G; Beghi E; Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602 [TBL] [Abstract][Full Text] [Related]
20. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Guidetti D; Bondavalli M; Sabadini R; Marcello N; Vinceti M; Cavalletti S; Marbini A; Gemignani F; Colombo A; Ferrari A; Vivoli G; Solimè F Neuroepidemiology; 1996; 15(6):301-12. PubMed ID: 8930943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]